| Identification | |
| Name: | Pazopanib |
| Synonyms: | 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;GW 786034;Benzenesulfonamide,5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-;Votrient; |
| CAS: | 444731-52-6 |
| Molecular Formula: | C21H23N7O2S |
| Molecular Weight: | 437.52 |
| InChI: | InChI=1/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H |
| Molecular Structure: | ![(C21H23N7O2S) 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;...](https://img.guidechem.com/casimg/444731-52-6.gif) |
| Properties | |
| Density: | 1.4 |
| Appearance: | White powder |
| Specification: |
Pazopanib , its cas register number 444731-52-6. It also can be called GW786034 ; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide; Pazopanib ; and UNII-7RN5DR86CK . Its classification code is Antineoplastic Agents. |
| Safety Data | |
 |
|
